I originally bought into this baby for HIV, as quite a few others with "Long-Holders Disease" did, and then Graph vs Host was a little extra sizzle. But then the prospect of treating cancers showed up, and that seemed like such a huge market and unmet need that I had to sell some more children and buy more. I still think it is the biggest upside for the share price, and whatever money the company makes from Covid will serve to pay for expedited trials to prove efficacy in various cancer treatments. This will take CYDY from the $20-$30 level (from Covid success) to the 50s and up. And then start adding in all the other myriad of treatment possibilities with this apparently miraculous little molecule. Still holding, still confidently presuming this is all going...
To The Moon Alice